1. Home
  2. UP vs PHVS Comparison

UP vs PHVS Comparison

Compare UP & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UP
  • PHVS
  • Stock Information
  • Founded
  • UP 2013
  • PHVS 2015
  • Country
  • UP United States
  • PHVS Switzerland
  • Employees
  • UP N/A
  • PHVS N/A
  • Industry
  • UP Aerospace
  • PHVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • UP Consumer Discretionary
  • PHVS Health Care
  • Exchange
  • UP Nasdaq
  • PHVS Nasdaq
  • Market Cap
  • UP 1.2B
  • PHVS 980.9M
  • IPO Year
  • UP N/A
  • PHVS 2021
  • Fundamental
  • Price
  • UP $1.40
  • PHVS $20.12
  • Analyst Decision
  • UP
  • PHVS Buy
  • Analyst Count
  • UP 0
  • PHVS 6
  • Target Price
  • UP N/A
  • PHVS $37.17
  • AVG Volume (30 Days)
  • UP 765.7K
  • PHVS 215.4K
  • Earning Date
  • UP 08-07-2025
  • PHVS 08-13-2025
  • Dividend Yield
  • UP N/A
  • PHVS N/A
  • EPS Growth
  • UP N/A
  • PHVS N/A
  • EPS
  • UP N/A
  • PHVS N/A
  • Revenue
  • UP $765,885,000.00
  • PHVS N/A
  • Revenue This Year
  • UP $174.46
  • PHVS N/A
  • Revenue Next Year
  • UP N/A
  • PHVS N/A
  • P/E Ratio
  • UP N/A
  • PHVS N/A
  • Revenue Growth
  • UP N/A
  • PHVS N/A
  • 52 Week Low
  • UP $0.74
  • PHVS $11.51
  • 52 Week High
  • UP $2.78
  • PHVS $26.33
  • Technical
  • Relative Strength Index (RSI)
  • UP 50.65
  • PHVS 48.68
  • Support Level
  • UP $1.30
  • PHVS $19.12
  • Resistance Level
  • UP $1.48
  • PHVS $22.30
  • Average True Range (ATR)
  • UP 0.10
  • PHVS 1.22
  • MACD
  • UP -0.01
  • PHVS -0.23
  • Stochastic Oscillator
  • UP 28.27
  • PHVS 22.17

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: